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manifestations. There has recently been a
growing interest in plasmapheresis-for ex-
ample in the case of the hyperviscosity
syndrome. Here, macroglobulinaemia is a
principal indication. The author has pre-
viously published a monograph on the
diagnosis and treatment of myeloma, and
he discusses in this book a number of
sequelae of this disease, including hyper-
calcaemia and its treatment. Another area
where the author has made original studies is
the malignant carcinoid syndrome. Here
the characteristic flush signals the presence
of special types of tumours.
The author is thus a prominent research
worker who has to his credit original con-
tributions in the field of paraneoplasia. In
this book he presents an excellent summary
of his own and others' experience and obser-
vations.
Paraneoplastic signals from the skin are
particularly valuable pointers to the possible
presence of a tumour. They are illustrated
in a colour plate, which furnishes the derm-
atologist with interesting material. This
presentation can also contribute to a number
of other specialities such as neurology,
nephrology, haematology and, perhaps
especially, endocrinology, where ectopic for-
mation of polypeptide hormones has recently
attracted great interest. The author points
to the interesting fact that practically all the
paraneoplastic manifestations caused by
chemically definable substances are due to the
formation ofectopic polypeptides. He teaches
us to distinguish between pathological pro-
ducts of the cancer cells and the topic ones,
including insulin, gastrin and glucagon in
pancreatic tumours and catecholamines in
pheochromocytoma. Waldenstrdm expresses
the view that the ectopic ones are due to
random de-repression ofthe system goverining
the synthesis of a certain polypeptide.
The comprehensive bibliography contains
over 500 publications. Surgeons are well
represented among the authors, perhaps
because the disappearance of the para-
neoplastic syndrome after radical surgery
often provides the convincing proof of its
direct connection with the tumour. When
discussing possible explanations, the author
often uses his extensive knowledge of the
chemical nature of some of the products that
can be formed in the tumours.
The book can increase our knowledge of
hitherto little-recognized aspects of the
diagnosis of cancer diseases, and also of the
biology of tumours and tumour cells.
J. EINHORN
In Vitro Aspects of Erythropoiesis. (Ed.)
M. J. MURPHY (1979). New York: Springer-
Verlag. 280 pp.
This book is a collection of 30 papers (plus
discussion) presented at a conference on
"In vitro aspects of erythropoiesis". Most of
the world's eminent people in this subject
were included in the programme, and
several authors make the -ork a useful
addition to one's library. For example,
Iscove and Wagemaker discuss very clearly
the differential regulation of BFU-E and
CFU-E; Testa and Dexter and Murphy et al.
bring out valuable information on the pro-
duction of BFU-E in long-term marrow
cultures; Urabe and Murphy present an
interesting technical development in the
miniaturization of the CFU-E assay which
could prove useful for clinical requirements.
On the other hand, 5 of the 30 papers ignore
the in vitro part ofthe title, while another one
is solely about lymphocytes. Overall, the
book is something ofa disappointment. There
is a sense of deja vu about the papers. Never-
theless, it is of course useful to have them
under one cover.
It was intended to be essentially a working
conference, to produce a recipe book aimed
at closer standardization of methodology
and nomenclature. The aims were laudable:
a detailed account of materials and methods;
an itemized account of agreed facts; identi-
fication of technical divergence between
investigators. However, it tends to fall
between the two stools of erythropoiesis
at the BFU-E/CFU-E level and a technical
workshop, with the result that the former
is only sketchily covered, whilst I would
hesitate to recommend it to a new student
for technical advice. Admittedly the technical
appendices are good. They might have been
even more useful if their form of presentation
had been standardized. Additionally a dis-
cussion of the similarities and differences (in
line with the conference directives) would
have been valuable. With respect to the
nomenclature, one observes the use of
"CFUe" throughout, but in several places
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places there is confusion as to which of the
two is ineant. Whilst there is no full agreement
on the exact form of nomenclature, it is
clear that the use of block capitals as used
earlier in this reviewN, (a recent workshop
publication (Blood Cells (1979) 5, 447) on
nomenclature specifically recommends at
least that much) easily removes this source of
confusion and/or error.
The discussion sections (often the most
informative part of such a work) suffer from
the fact that they are presented as a con-
tinuum at the end of each section. It is
frequently difficult to determine to whom a
question is addressed and to what specific
point it refers. A collective discussion can
work well at a conference but requires very
careful editing when presented in a subse-
quent printed version. The English is con-
sistently infuriating and apart from badly con-
structed sentences there are many examples
of old chestnuts. For example, "a number"
is a singular noun, and used as the subject of
a sentence requires the singular form of the
verb. There are several "single media" plus
a survival optima" and, of course, split
infinitives abound.
The specialist (and in particular the con-
ference participants) will find the book
valuable. I, in spite of its shortcomings, am
happy to have a copy on my bookshelf.
B. I. LORD
Treatment of Radioresistant Cancers.
(Eds) M. ABE, K. SAKAMOTO & T. L.
PHILIPS (1979). New York: Elsevier. 230pp.
This volume is the proceedings in camera-
ready form of an International Symposium
on the prospects for treatment of radio-
resistant cancers, held in Kyoto in May 1979.
The title will appeal instantly to optimistic
and forward-looking radiotherapists, but
they will be disappointed, as the subject of
the title is discussed diirectly only in 2
chapters in the last section, in which there is
a short review of soft-tissue sarcoma (Suit)
including some new data, with the opinion
that these tumours should not now be
considered particularly radioresistant, and a
trial of uneven fractionation r-eported for
bronchogenic carcinoma (Takahashi) using
600 rad plus 4 subsequent fractions of 120
irad each week for 5 weeks. However, the
results, slightly better than for historical
conventional treatments, are no better than
others have claimed for conventional sched-
ules. The use of bleomycin and radiotherapy
for oral carcinoma is described (Shigematsu),
but the true benefit from BLM cannot be
elucidated from the series presented. The
section concludes with a study on the vas-
culature of mouse tumours using resin casts
(Egawa)-technically very satisfying, buit
difficult to quantitate and interpret.
There are 2 sections on methods to over-
come the resistance of most tumours, if this
is caused by hypoxic tumour cells, as is
generally believed. Radiosensitizer scientists
are well represented by Adams (problems and
prospects) Arcangeli (clinical treatnients)
and Phillips (studies in USA). These papers
are right up to date, and usefully concise.
The clinical studies are clearly work-in-
progress, and as yet inconclusive about real
benefit.
High-LET radiation receives good atten-
tion, with neutrons, pions, and heavy ions
being discussed. New biological measurements
with 6 MeV neutrons and pions (Sakamoto)
is followed by the use of 252Cf in a series of
60 patients. This series is well presented, but
is non-randomized and difficult to assess in
relation to conventional treatments. There
is a good trial of fast neutrons (30 MeV d on
Be) using 400 patients (Tsumemoto). The
largest group (cervix-III-B) shows equivalent
local control (neutron/photon) with slightly
more complications after neutrons. Pions
are described at Vancouver (Skarsgard) and
Los Alamos (Kligerman)-the latest inform-
ation, and concisely written. This section
concludes with heavy-ion studies at Berkeley
(Tobias).
The fourth section is on hyperthermia,
containing a good review (Johnson) to join
several others now available. Data are pre-
sented for mouse tumours and foot skin
reactions (Urano) and for a human mel-
anoma cell line (Streffer) showing nuclear
damage after heat.
In general, this is a very mixed collection
ofpapers, with some very good short reviews,
some varying clinical studies, and some
experimental work which should probably
go first into the open literature. The book
does not really deserve its title, although if
retitled 'The current status of new treatments
in radiotherapy' this volume would be a
reasonable attempt.
J. H. HENDRY